Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

TTOO | T2 Biosystems Inc

Index- P/E- EPS (ttm)-5.75 Insider Own6.59% Shs Outstand333.58M Perf Week-13.03%
Market Cap73.69M Forward P/E- EPS next Y-0.52 Insider Trans-68.74% Shs Float311.60M Perf Month-31.82%
Income-52.43M PEG- EPS next Q-0.17 Inst Own2.09% Short Float / Ratio7.61% / 0.20 Perf Quarter212.89%
Sales13.20M P/S5.58 EPS this Y92.27% Inst Trans0.43% Short Interest23.71M Perf Half Y-51.98%
Book/sh-0.15 P/B- EPS next Y45.12% ROA-135.79% Target Price0.15 Perf Year-95.91%
Cash/sh0.05 P/C4.58 EPS next 5Y- ROE- 52W Range0.05 - 5.72 Perf YTD-84.44%
Dividend- P/FCF- EPS past 5Y33.92% ROI- 52W High-96.14% Beta0.39
Dividend %- Quick Ratio0.30 Sales past 5Y51.24% Gross Margin-42.53% 52W Low309.07% ATR0.07
Employees158 Current Ratio0.36 Sales Q/Q-66.77% Oper. Margin-389.12% RSI (14)44.35 Volatility20.97% 19.79%
OptionableYes Debt/Eq- EPS Q/Q98.46% Profit Margin-397.14% Rel Volume0.93 Prev Close0.18
ShortableYes LT Debt/Eq- EarningsAug 07 AMC Payout- Avg Volume116.44M Price0.22
Recom3.00 SMA20-23.20% SMA50-25.96% SMA200-61.89% Volume107,923,883 Change23.89%
Date Action Analyst Rating Change Price Target Change
Jan-27-21Downgrade Alliance Global Partners Buy → Neutral $2.60 → $2.40
Oct-08-20Initiated BTIG Research Buy $2.50
Nov-26-19Downgrade Janney Buy → Neutral
Aug-01-19Downgrade Alliance Global Partners Buy → Neutral
Jul-31-19Downgrade Janney Buy → Neutral
Jul-31-19Downgrade H.C. Wainwright Buy → Neutral
May-16-19Initiated Alliance Global Partners Buy $5
Mar-08-19Reiterated H.C. Wainwright Buy $14 → $11
Jun-01-18Upgrade Leerink Partners Mkt Perform → Outperform
May-30-18Reiterated H.C. Wainwright Buy $8.50 → $14
Sep-19-23 09:00AM
Sep-15-23 04:05PM
Sep-11-23 03:52PM
Sep-07-23 04:05PM
Aug-28-23 08:30AM
12:35PM Loading…
Aug-24-23 12:35PM
Aug-15-23 10:20AM
Aug-14-23 12:38PM
Aug-10-23 11:11AM
Aug-09-23 06:10PM
Aug-08-23 07:42AM
Aug-07-23 04:22PM
04:05PM Loading…
Jul-31-23 09:29PM
Jul-28-23 08:30AM
Jul-24-23 04:05PM
Jul-21-23 04:05PM
Jul-20-23 08:30AM
Jul-12-23 03:59PM
Jul-06-23 08:00AM
Jun-09-23 09:15AM
Jun-05-23 09:00AM
May-30-23 09:00AM
May-23-23 11:12PM
08:05AM Loading…
May-22-23 08:15AM
May-19-23 09:22AM
May-17-23 04:05PM
May-15-23 04:05PM
May-01-23 04:05PM
Apr-26-23 08:30AM
Apr-19-23 03:39PM
Apr-05-23 08:00AM
Mar-23-23 09:00AM
Mar-14-23 11:12AM
Mar-13-23 04:05PM
Mar-03-23 08:00AM
Feb-15-23 07:30AM
Feb-14-23 05:29AM
Feb-13-23 04:19PM
Feb-06-23 04:05PM
Feb-03-23 04:30PM
Jan-23-23 04:30PM
Dec-28-22 09:00AM
Dec-08-22 08:28AM
Nov-16-22 05:08AM
Nov-10-22 04:05PM
Nov-09-22 04:05PM
Nov-07-22 08:30AM
Nov-01-22 08:30AM
Oct-31-22 05:57PM
Oct-20-22 09:05AM
Oct-14-22 08:30AM
Oct-13-22 09:00AM
Oct-12-22 10:59AM
Sep-29-22 08:30AM
Sep-23-22 07:50AM
Sep-22-22 04:05PM
Sep-08-22 04:05PM
Aug-18-22 04:05PM
Aug-16-22 08:30AM
Aug-15-22 04:05PM
Aug-09-22 08:30AM
Aug-05-22 04:43PM
Jul-29-22 04:05PM
Jul-28-22 04:32PM
Jul-27-22 04:05PM
Jul-11-22 08:00AM
Jul-06-22 10:21AM
Jun-15-22 04:05PM
Jun-10-22 09:00AM
May-20-22 09:17AM
May-05-22 04:05PM
Apr-28-22 08:30AM
Apr-27-22 08:30AM
Apr-21-22 04:05PM
Apr-14-22 04:05PM
Mar-31-22 04:57PM
Mar-29-22 08:00AM
Feb-17-22 04:05PM
Feb-16-22 09:00AM
Feb-15-22 09:27AM
Feb-08-22 04:05PM
Feb-04-22 04:05PM
T2 Biosystems, Inc. engages in the development of a proprietary technology platform. It offers the T2 Magnetic Resonance technology, which enables detection of pathogens, biomarkers, and other abnormalities in a range of unpurified patient sample types. The firm's products include the T2Dx Instrument, the T2Candida Panel, the T2Bacteria Panel, the T2Resistance Panel, and the T2SARS-CoV-2 Panel. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CR Group L.P.10% OwnerSep 28Sale0.167,148,9451,125,9590Sep 29 04:30 PM
CR Group L.P.10% OwnerSep 27Sale0.195,981,2021,145,998571,796Sep 29 04:30 PM
CR Group L.P.10% OwnerSep 26Sale0.205,392,9201,082,3591,050,192Sep 28 04:30 PM
CR Group L.P.10% OwnerSep 25Sale0.25250,00062,5001,481,535Sep 27 05:53 PM
CR Group L.P.10% OwnerSep 22Sale0.265,079,3441,314,5341,501,531Sep 26 05:15 PM
CR Group L.P.10% OwnerSep 21Sale0.306,338,2111,904,6321,907,794Sep 25 08:30 PM
CR Group L.P.10% OwnerSep 20Sale0.317,753,7102,408,3022,414,745Sep 22 04:15 PM
CR Group L.P.10% OwnerSep 19Sale0.3710,401,4663,806,9373,034,912Sep 21 04:30 PM
Gibbs Michael TerrenceGeneral CounselMar 28Sale0.482391156,612Apr 06 01:08 PM
Sperzel John J IIIChairman and CEOFeb 28Sale0.592,8981,71017,329Mar 09 04:00 PM
Gibbs Michael TerrenceGeneral CounselFeb 28Sale0.591,5859356,517Mar 09 04:00 PM
Sprague John MChief Financial OfficerFeb 28Sale0.591,1486777,268Mar 09 04:00 PM
Sperzel John J IIIChairman and CEOFeb 22Sale0.656,8754,46913,560Mar 09 04:00 PM
Gibbs Michael TerrenceGeneral CounselFeb 22Sale0.652,1451,3945,188Mar 09 04:00 PM
Sprague John MChief Financial OfficerFeb 22Sale0.651,5451,0045,502Mar 09 04:00 PM
Giffin Brett A.Chief Commercial OfficerFeb 22Sale0.65537349841Mar 09 04:00 PM
Giffin Brett A.Chief Commercial OfficerNov 10Sale1.791,2922,3172,253Nov 22 04:00 PM